California Healthline January 17, 2023
Darius Tahir

SAN FRANCISCO — Health care’s business class returned to its San Francisco sanctuary last week for JPMorgan’s annual health care confab, at the gilded Westin St. Francis hotel on Union Square. After a two-year pandemic pause, the mood among the executives, bankers, and startup founders in attendance had the aura of a reunion — as they gossiped about promotions, work-from-home routines, who’s getting what investments. Dressed in their capitalist best — ranging from brilliant-blue or pastel-purple blazers to puffy-coat chic — they thronged to big parties, housed in art galleries or restaurants.

But the party was tinged with new anxiety: Would the big money invested in health care due to covid-19 continue to flow? Would investors ask to see results...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Investments, Trends
Is AI Good for Health Equity? California Leaders Weigh In
RSAC 2024: Vendors sign CISA's secure by design pledge
What health systems need to 'win in every market'
How Peter Marks plans to prevent '3 billion visits' to FDA
For every million-dollar gene therapy, Peter Marks gets an email from FDA chief Robert Califf

Share This Article